Editorial Board

Composed of distinguished scholars engaged in scientific and clinical research, our Editorial Board is dedicated to the furtherance of the study of the role of the immune system in cancer development and control and its use in the treatment of cancer. Leading tumor immunologists, Coley Award winners, and members of the National Academy of Sciences and the Academy of Cancer Immunology provide their expertise spanning the entire range of issues relevant to cancer immunology and immunotherapy.

Editor-in-Chief

James P. Allison, Ph.D.
The University of Texas MD Anderson Cancer Center, Houston, TX

Deputy Editor-in-Chief

Pramod K. Srivastava, M.D., Ph.D.
University of Connecticut School of Medicine, Farmington, CT

Associate Editors

Vincenzo Cerundolo, M.D., Ph.D.
University of Oxford, Oxford, United Kingdom

Alexander Knuth, M.D.
University Hospital Zürich, Zürich, Switzerland

Cornelis J.M. Melief, M.D., Ph.D.
Leiden University Medical Center, Leiden, The Netherlands

Robert D. Schreiber, Ph.D.
Washington University School of Medicine, St. Louis, MO

Contributing Editors

Yao-Tseng Chen, M.D., Ph.D.
Weill Medical College of Cornell University New York, NY

Pierre G. Coulie, Ph.D.
de Duve Institute Brussels, Belgium

Glenn Dranoff, M.D.
Dana-Farber Cancer Institute Boston, MA

Guido Forni, M.D.
Molecular Biotechnology Center Torino, Italy

Sacha Gnjatic, Ph.D.
Mount Sinai School of Medicine, New York, NY

Axel Hoos, M.D., Ph.D.
Glaxo Smith Kline Philadelphia, PA

Elke Jäger, M.D.
Krankenhaus Nordwest Frankfurt, Germany

Klas Kärre, M.D., Ph.D.
Karolinska Institute Stockholm, Sweden

Yutaka Kawakami, M.D., Ph.D.
Keio University School of Medicine Tokyo, Japan

John M. Kirkwood, M.D.
University of Pittsburgh School of Medicine Pittsburgh, PA

Eva Klein, M.D.
Karolinska Institute Stockholm, Sweden

George Klein, M.D., D.Sc.
Karolinska Institute Stockholm, Sweden

Jean-Pierre Mach, M.D.
University of Lausanne Epalinges, Switzerland

Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute Buffalo, NY

Drew M. Pardoll, M.D., Ph.D.
Sidney Kimmel Comprehensive-Cancer Center at Johns Hopkins Baltimore, MD

Giorgio Parmiani, M.D.
H. San Raffaele Scientific Institute Milan, Italy

Hans-Georg Rammensee, Ph.D.
University of Tübingen Tübingen, Germany

Jeffrey V. Ravetch, M.D., Ph.D.
The Rockefeller University New York, NY

Pedro Romero, M.D.
Ludwig Institute for Cancer Research at University of Lausanne Lausanne, Switzerland

Alexander Rudensky, Ph.D.
Sloan-Kettering Institute for Cancer Research New York, NY

Shimon Sakaguchi, M.D., Ph.D.
Institute for Frontier Medical Sciences at Kyoto University Kyoto, Japan

Hans Schreiber, M.D., Ph.D.
The University of Chicago Chicago, IL

Padmanee Sharma, M.D., Ph.D.
The University of Texas MD Anderson Cancer Center Houston, TX

Hiroshi Shiku, M.D.
Mie University Graduate School of Medicine Mie, Japan

Mark J. Smyth, Ph.D.
Peter MacCallum Cancer Center Melbourne, Australia

Daniel Speiser, M.D.
Ludwig Institute for Cancer Research at University of Lausanne Lausanne, Switzerland

Giorgio Trinchieri, M.D.
National Cancer Institute Frederick, MD

Danila Valmori, Ph.D.
INSERM Saint Herblain, France

Benoit Van den Eynde, M.D., Ph.D.
Ludwig Institute for Cancer Research at de Duve Institute Brussels, Belgium

Pierre van der Bruggen, Ph.D.
Ludwig Institute for Cancer Research at de Duve Institute Brussels, Belgium

Ellen S. Vitetta, Ph.D.
UT Southwestern Medical Center Dallas, TX

Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center New York, NY

Cassian Yee, M.D.
Fred Hutchinson Cancer Research Center Seattle, WA